Log in

Relevant bibliographies by topics / Yifeng tang

Contents

Journal articles
Books
Book chapters

Academic literature on the topic 'Yifeng tang'

Author: Grafiati

Published: 27 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Yifeng tang.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Yifeng tang"

1

Han, Wu, Jie Liu, Yifan Luo, and Hongqu Tang. "No longer endemic to Africa: Kribiodosis Kieffer, 1921 (Diptera, Chironomidae) new to Oriental China with a phylogeny and expanded adult generic diagnoses." Zootaxa 5072, no. 6 (2021): 560–74. https://doi.org/10.11646/zootaxa.5072.6.4.

Full text

Abstract:

Han, Wu, Liu, Jie, Luo, Yifan, Tang, Hongqu (2021): No longer endemic to Africa: Kribiodosis Kieffer, 1921 (Diptera, Chironomidae) new to Oriental China with a phylogeny and expanded adult generic diagnoses. Zootaxa 5072 (6): 560-574, DOI: 10.11646/zootaxa.5072.6.4

APA, Harvard, Vancouver, ISO, and other styles

2

Hamer, Matthew T., André Ibáñez Weemaels, Yifan Fu, et al. "New insights into the diversity and distribution of Leptanillinae (Formicidae) within China." Zootaxa 5471, no. 1 (2024): 99–112. https://doi.org/10.11646/zootaxa.5471.1.6.

Full text

Abstract:

Hamer, Matthew T., Weemaels, André Ibáñez, Fu, Yifan, Xuan, Liu, Tse, Cheung Yau Leo, Tang, Kit Lam, Guénard, Benoit (2024): New insights into the diversity and distribution of Leptanillinae (Formicidae) within China. Zootaxa 5471 (1): 99-112, DOI: 10.11646/zootaxa.5471.1.6, URL: http://dx.doi.org/10.11646/zootaxa.5471.1.6

APA, Harvard, Vancouver, ISO, and other styles

3

Dong1, Yang, Shengchang Duan1, Qiuju Xia, et al. "Dual domestications and origin of traits in grapevine evolution." Science 379 (March 3, 2023): 892–901. https://doi.org/10.1126/science.add8655.

Full text

Abstract:

Dong1, Yang, Duan1, Shengchang, Xia, Qiuju, Liang, Zhenchang, Dong1, Xiao, Margaryan, Kristine, Musayev, Mirza, Goryslavets, Svitlana, Zduni, Goran, Bert, Pierre-François, Lacombe11, Thierry, Maul1, Erika, Nick, Peter, Bitskinashvili, Kakha, Bisztray, György Dénes, Drori, Elyashiv, Lorenzis, Gabriella De, Cunha, Jorge, Popescu, Carmen Florentina, Arroyo-Garcia, Rosa, Arnold, Claire, Ergül, Ali, Zhu1, Yifan, Ma, Chao, Wang, Shufen, Liu1, Siqi, Tang, Liu, Wang, Chunping, Li, Dawei, Pan, Yunbing (2023): Dual domestications and origin of traits in grapevine evolution. Science 379: 892-901, DOI: 10

APA, Harvard, Vancouver, ISO, and other styles

4

Cortes-Cros, Marta, Henrik Moebitz, Stephanie Barbe, et al. "Abstract PR007: Discovery of HRO761, a novel, first-in-class clinical stage WRN inhibitor with potent and selective anti-tumor activity in cancers with microsatellite instability." Molecular Cancer Therapeutics 22, no. 12_Supplement (2023): PR007. http://dx.doi.org/10.1158/1535-7163.targ-23-pr007.

Full text

Abstract:

Abstract The RecQ DNA helicase WRN was identified as a synthetic lethal target in tumors with microsatellite instability (MSI) by several genetic screens. Despite recent advances in the treatment of MSI tumors by immune checkpoint inhibitors, a significant proportion of patients still fails to respond to or relapses after single agent anti-PD1 or combination of anti-PD1 plus anti-CTLA4 treatments. We present the biochemical, cellular and pharmacological characterization of the first potent and selective WRN helicase inhibitor, HRO761. We show that HRO761 is an allosteric WRN inhibitor that bin

APA, Harvard, Vancouver, ISO, and other styles

5

Zhou, Yifan, Yusra B. Medik, Bhakti Patel, et al. "Abstract 5545: Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration." Cancer Research 82, no. 12_Supplement (2022): 5545. http://dx.doi.org/10.1158/1538-7445.am2022-5545.

Full text

Abstract:

Abstract Immunotherapies such as anti-CTLA-4 immune checkpoint blockade (ICB) have revolutionized cancer treatment, yet quality of life and continuation of therapy can be constrained by off-target tissue damage or immune-related adverse events (irAEs). At present, there is limited understanding of irAE mechanisms, hampering development of approaches to mitigate their damage. We addressed this problem by generating animal models of intestinal irAE. Our results show that disruption of homeostatic immunity by genetic predisposition to intestinal inflammation or acute gastrointestinal infection se

APA, Harvard, Vancouver, ISO, and other styles

6

Yang, Cuiqing, Yifang Wang, Tingting Liu, et al. "Abstract 2899: Small molecule inhibitor of ubiquitin ligase CBL-B enhanced anti-tumor response of CAR-T and CAR-NK cell therapies." Cancer Research 83, no. 7_Supplement (2023): 2899. http://dx.doi.org/10.1158/1538-7445.am2023-2899.

Full text

Abstract:

Abstract Introduction: Chimeric antigen receptor (CAR) T-cell therapy is an emerging therapeutic option for cancer treatment. However, its efficacy is limited, especially in solid tumors. This is partly because the CAR T cells become dysfunctional and exhausted in the tumor microenvironment. However, the key pathways responsible for impaired function of exhausted T cells remain unclear. Immunosuppressive cytokines or checkpoint proteins like TGF-β and PD-L1, are overproduced, which may lead to the downregulation of CD8+ T cell action and the promotion of T-reg maturation. E3 ligase Casitas B-L

APA, Harvard, Vancouver, ISO, and other styles

7

Wang, Xiaobin Summer, Sining Zhu, Haili Ding, et al. "Abstract 360: Discovery of selective and orally bioavailable PKMYT1 inhibitor: characterization of anti-tumor activities as single and dual agents." Cancer Research 85, no. 8_Supplement_1 (2025): 360. https://doi.org/10.1158/1538-7445.am2025-360.

Full text

Abstract:

Abstract Advancing effective cancer therapies requires innovative approaches to better understand complex biological interactions. PKMYT1, a crucial regulator of the cell cycle involved in the G2/M transition through inhibitory phosphorylation of CDK1, has emerged as a promising therapeutic target. Inactivation of PKMYT1 is synthetically lethal in tumor cells with genomic alterations leading to high replication stress, such as CCNE1 amplification, which is frequently found in high-grade serous ovarian, uterine, and gastro-esophageal cancers. In this report, we present a series of potent PKMYT1

APA, Harvard, Vancouver, ISO, and other styles

8

Yang, Cuiqing, Fuwei Jiang, Yifang Wang, et al. "Abstract 2900: To develop a next generation NK therapy with deep and durable response by engineered CD16 enhancing NK cytotoxicity." Cancer Research 83, no. 7_Supplement (2023): 2900. http://dx.doi.org/10.1158/1538-7445.am2023-2900.

Full text

Abstract:

Abstract Introduction: Allogeneic NK cell-based therapies have been demonstrated to elicit clinical efficacy against hematopoietic malignancies. Unlike T-cell therapies, allogeneic NK cells do not cause toxicities such as serious cytokine release syndrome, neurotoxicity, or graft-vs-host-disease, and are less expensive. We believe NK cell-based therapies provide an important platform for “off-shelf” allogeneic cell therapies, so we designed a panel of arming strategies to enhance NK cytotoxicity and elicit deep and durable response. CD16a is a transmembrane protein that co-localizes with CD3ζ

APA, Harvard, Vancouver, ISO, and other styles

9

Yang, Cuiqing, Fuwei Jiang, Yifang Wang, et al. "Abstract 4087: Co-expression of membrane bound IL-15 enhanced anti-tumor response of CAR-T." Cancer Research 83, no. 7_Supplement (2023): 4087. http://dx.doi.org/10.1158/1538-7445.am2023-4087.

Full text

Abstract:

Abstract Introduction: Chimeric antigen receptors (CARs) T cells have been used successfully to treat patients with hematologic malignancies, but showed less effective in solid tumors. We investigated multiple approaches to engineer and enhance CAR-T activity in solid tumors. It has been previously reported that improvement in the quality of CAR-T cells, through CAR design or manufacturing optimization, could enhance the therapeutic potential of CAR-T cells. One parameter influencing the effectiveness of CAR-T cell therapy is the differentiation status of the final product: CAR-T cells that ar

APA, Harvard, Vancouver, ISO, and other styles

10

Yang, Cuiqing, Yifang Wang, Tingting Liu, et al. "Abstract 4078: Optimized chimeric antigen receptors (CARs) for CAR-NK cell therapies." Cancer Research 83, no. 7_Supplement (2023): 4078. http://dx.doi.org/10.1158/1538-7445.am2023-4078.

Full text

Abstract:

Abstract Introduction: CAR-T-cell therapy has shown great success in treating hematopoietic malignancies. Allogenic NK cell-based therapies have also been shown to mount potent responses against hematopoietic malignancies. Unlike T-cell therapies, allogeneic NK cells do not cause toxicities such as serious cytokine release syndrome, neurotoxicity, or graft-vs-host-disease. Several groups have demonstrated the clinical efficacy of allogeneic CAR-expressing NK cells that utilize CARs developed for T-cells. However, activating receptor signaling in NK cells is different from T cells. NK cell-medi

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Yifeng tang"

1

Ming, Huang, та Yang Tongfu, ред. 藝風藏書記. Shanghai gu ji chu ban she, 2007.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Yifeng tang wen ji. Zhao hua chu ban she, 2017.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Yifeng tang shi cun: [4 juan] ; Bi xiang ci : [1 juan]. Beijing shi Zhongguo shu dian, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Yifeng tang"

1

Tan, Jiarui, Yifan Li, and Holger Briel. "Growing Up a Pirate." In The Piracy Years. Liverpool University Press, 2023. http://dx.doi.org/10.3828/liverpool/9781802070545.003.0009.

Full text

Abstract:

This chapter contains testimonials by Jiarui Tan and Yifan Li, both of whom display a passion for their preferred medium: music and video gaming respectively. Their narratives give a detailed account of different kinds of structures informing and sharing media discourses and speak of their inventiveness in overcoming such strictures. It explores how much the emerging online community of gamers and music fans has succeeded in creating new collaborations, growing up and enlarging horizons together. The chapter illustrates the liberating, emancipatory, and lasting power of media piracy and the wa

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!